Commercial Coverage After May 11, 2023
The temporary provisions to waive cost sharing for COVID-19 vaccines, testing, and related services ordered by a physician or other provider, and over-the-counter (OTC) tests (eight per member per month) ended on May 11, 2023.
COVID-19 OTC at-home test kits are still covered as follows:
- With prescription: covered under your plan pharmacy benefits at the tier 1 cost share and are limited to four tests per month unless medically necessary
- Without a prescription: not covered
Medicaid Coverage After May 11, 2023
COVID-19 over the counter (OTC) at-home test kits will continue to be covered.